88 related articles for article (PubMed ID: 21604582)
1. [Determination of circulating HBV specific CD8+ T cells in hepatitis B patients by flow cytometry and its clinical significance].
Yao YL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):476-8. PubMed ID: 21604582
[TBL] [Abstract][Full Text] [Related]
2. [Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B].
Lee CK; Suh JH; Cho YS; Han KH; Chung JB; Chon CY; Moon YM
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):139-48. PubMed ID: 12499799
[TBL] [Abstract][Full Text] [Related]
3. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
4. [Chemokine receptor expression of hepatitis B virus-specific CD8+ lymphocyte in chronic B viral infection].
Lee CK; Suh JH; Cho YS; Han KH; Chung JB; Chon CY; Moon YM
Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):363-70. PubMed ID: 12506240
[TBL] [Abstract][Full Text] [Related]
5. Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection.
Urbani S; Boni C; Amadei B; Fisicaro P; Cerioni S; Valli MA; Missale G; Ferrari C
Hepatology; 2005 Apr; 41(4):826-31. PubMed ID: 15726541
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients.
Mancini-Bourgine M; Bayard F; Soussan P; Deng Q; Lone YC; Kremsdorf D; Michel ML
J Virol; 2007 May; 81(10):4963-72. PubMed ID: 17360751
[TBL] [Abstract][Full Text] [Related]
7. The impact of HBV-DNA fluctuations on virus-specific CD8+ T cells in HBeAg+ chronic hepatitis B patients treated with a steroid and lamivudine.
Gotto J; Webster GJ; Brown D; Jenkins J; Dusheiko GM; Bertoletti A
J Viral Hepat; 2006 Jun; 13(6):415-25. PubMed ID: 16842445
[TBL] [Abstract][Full Text] [Related]
8. Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection.
Boni C; Amadei B; Urbani S; Fisicaro P; Zerbini A; Mori C; Missale G; Bertoni R; Azzurri A; Del Prete G; Ferrari C
Hepatology; 2004 Aug; 40(2):289-99. PubMed ID: 15368433
[TBL] [Abstract][Full Text] [Related]
9. [PD-1 up-regulation influenced apoptosis of HBV-specific CD8 T cells in patients with acute resolved hepatitis B].
Xu B; Zhang Z; Shi Y; Chen XY; Wang FS
Zhonghua Yi Xue Za Zhi; 2009 May; 89(17):1158-61. PubMed ID: 19595077
[TBL] [Abstract][Full Text] [Related]
10. CD8low T-cell subpopulation is increased in patients with chronic hepatitis B virus infection.
Ouyang L; Li X; Liang Z; Yang D; Gong F; Shen G; Weng X; Wu X
Mol Immunol; 2013 Dec; 56(4):698-704. PubMed ID: 23933510
[TBL] [Abstract][Full Text] [Related]
11. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
[TBL] [Abstract][Full Text] [Related]
12. Tracking the source of the hepatitis B virus-specific CD8 T cells during lamivudine treatment.
Malacarne F; Webster GJ; Reignat S; Gotto J; Behboudi S; Burroughs AK; Dusheiko GM; Williams R; Bertoletti A
J Infect Dis; 2003 Feb; 187(4):679-82. PubMed ID: 12599086
[TBL] [Abstract][Full Text] [Related]
13. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.
Zerbini A; Pilli M; Boni C; Fisicaro P; Penna A; Di Vincenzo P; Giuberti T; Orlandini A; Raffa G; Pollicino T; Raimondo G; Ferrari C; Missale G
Gastroenterology; 2008 May; 134(5):1470-81. PubMed ID: 18355815
[TBL] [Abstract][Full Text] [Related]
14. A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment.
Tsai SL; Lee TH; Chien RN; Liao SK; Lin CL; Kuo GC; Liaw YF
J Immunol Methods; 2004 Feb; 285(1):71-87. PubMed ID: 14871536
[TBL] [Abstract][Full Text] [Related]
15. [HBV-specific CD8+ T cells for sustained HBeAg seroconversion after lamivudine therapy].
Lee CK; Han KH; Suh JH; Cho YS; Won SY; Chon CY; Moon YM; Park IS
Korean J Hepatol; 2005 Mar; 11(1):34-42. PubMed ID: 15788883
[TBL] [Abstract][Full Text] [Related]
16. Alterations in hepatitis B virus nucleotide sequences in a chronic virus carrier from immunotolerant to immunoactive phase.
Ohkawa K; Takehara T; Tatsumi T; Ishida H; Deguchi M; Kagita M; Hosui A; Miyagi T; Katayama K; Hayashi N
Biochem Biophys Res Commun; 2010 Apr; 394(3):574-80. PubMed ID: 20214885
[TBL] [Abstract][Full Text] [Related]
17. Effect of regulatory T cells and adherent cells on the expansion of HBcAg-specific CD8+ T cells in patients with chronic hepatitis B virus infection.
Li X; Chen Y; Ma Z; Ye B; Wu W; Li L
Cell Immunol; 2010; 264(1):42-6. PubMed ID: 20483408
[TBL] [Abstract][Full Text] [Related]
18. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
[TBL] [Abstract][Full Text] [Related]
19. [Changes of antigen-specific cytotoxic T lymphocytes during acute flare-ups in chronic hepatitis B patients].
Deng H; Chong YT; Han XY; Zhang FC; Peng XM; Gao ZL; Yao JL
Zhonghua Gan Zang Bing Za Zhi; 2006 Oct; 14(10):721-4. PubMed ID: 17064461
[TBL] [Abstract][Full Text] [Related]
20. CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions.
Phillips S; Chokshi S; Riva A; Evans A; Williams R; Naoumov NV
J Immunol; 2010 Jan; 184(1):287-95. PubMed ID: 19949099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
